Almanac Health, a provider of an AI-powered point of care evidence-based clinical decision support platform for healthcare providers, raised $10 million in Seed funding.
Including the latest Seed round, Almanac Health has raised approximately $12 million in funding to date.
F-Prime Capital led the investment round with participation from General Catalyst and Lightspeed Venture Partners.
With fresh funds, Almanac Health plans to accelerate its platform development work to bring safe, evidence-grounded AI to clinicians and health systems. The funding will provide resources for the startup to expand its team across clinical medicine, AI research, and health systems infrastructure, as well as advance R&D with a focus on privacy, reliability, and rigorous evaluation before deployment.
Almanac Health is currently hiring across engineering, AI research, and clinical development.
“There is no shortage of technologies promising to transform medicine. But few are grounded in real evidence, built with integrity, and deserving of trust from the people and organizations using them. Almanac Health’s goal is to build clinical AI held to that standard. Validated through research, with incentives aligned with clinicians and patients. We’re focused on getting that right,” said Cyril Zakka, MD, founder and CEO of Almanac Health.
Digital health companies, including clinical decision support startups, have secured more than $180 billion in funding to date, according to our recent Funding Database.
AI-driven digital health startups have secured billions of dollars in funding so far in 2026. Notable recent funding rounds include:
- Ethermed, a healthcare technology startup building AI-driven automation for prior authorization and medical-necessity workflows, raised $8.5 million in Series A funding to expand its enterprise platform and scale its growing network of health-system partners.
- Joyful Health, a provider of AI financial infrastructure for healthcare revenue operations, raised $17 million in Series A funding to build a financial operating system for healthcare providers.
- Luminai, a provider of an AI-powered healthcare workflow automation platform, raised $38 million in a Series B funding round, bringing its total funding to date to $60 million.
- Click Therapeutics, a developer of AI-based digital therapeutics, raised $50 million in Series D funding from Boehringer Ingelheim to support the commercialization of its CT-155, an investigational prescription digital therapeutic that is being studied for the treatment of the experiential negative symptoms of schizophrenia in adults aged 18 years and older.